Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Dual Antiplatelet Therapy Study (DAPT Study)

This study is ongoing, but not recruiting participants.
Boston Scientific Corporation
Bristol-Myers Squibb
Cordis Corporation
Eli Lilly and Company
Daiichi Sankyo Inc.
Information provided by (Responsible Party):
Harvard Clinical Research Institute Identifier:
First received: September 14, 2009
Last updated: November 14, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
No publications provided by Harvard Clinical Research Institute

Publications automatically indexed to this study by Identifier (NCT Number):